Melissa L. Danielson

ORCID: 0000-0001-9461-0341
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Attention Deficit Hyperactivity Disorder
  • Child and Adolescent Psychosocial and Emotional Development
  • Autism Spectrum Disorder Research
  • Obsessive-Compulsive Spectrum Disorders
  • Infant Development and Preterm Care
  • Child and Adolescent Health
  • Children's Physical and Motor Development
  • Maternal Mental Health During Pregnancy and Postpartum
  • Adolescent and Pediatric Healthcare
  • Chronic Obstructive Pulmonary Disease (COPD) Research
  • Early Childhood Education and Development
  • COVID-19 and healthcare impacts
  • COVID-19 Clinical Research Studies
  • Childhood Cancer Survivors' Quality of Life
  • Food Security and Health in Diverse Populations
  • Smoking Behavior and Cessation
  • COVID-19 and Mental Health
  • Family and Disability Support Research
  • Eating Disorders and Behaviors
  • Respiratory Support and Mechanisms
  • Health disparities and outcomes
  • Frailty in Older Adults
  • Behavioral and Psychological Studies
  • Child Nutrition and Feeding Issues
  • Bullying, Victimization, and Aggression

National Center on Birth Defects and Developmental Disabilities
2016-2025

Centers for Disease Control and Prevention
2015-2024

Centers for Disease Control and Prevention
2023

AID Atlanta
2023

Computer Emergency Response Team
2020

CDC Foundation
2020

Response Biomedical (Canada)
2019

University of Pittsburgh
2018

Georgia Institute of Technology
2018

Truven Health Analytics (United States)
2018

Mental health encompasses a range of mental, emotional, social, and behavioral functioning occurs along continuum from good to poor. Previous research has documented that mental among children adolescents is associated with immediate long-term physical chronic disease, risk behaviors, social relationships, education, employment. Public surveillance children's can be used monitor trends in prevalence across populations, increase knowledge about demographic geographic differences, support...

10.15585/mmwr.su7102a1 article EN MMWR Supplements 2022-02-24

The purpose of this study is to estimate the national prevalence parent-reported attention deficit/hyperactivity disorder (ADHD) diagnosis and treatment among U.S. children 2–17 years age using 2016 National Survey Children's Health (NSCH). NSCH a nationally representative, cross-sectional survey parents regarding their children's health that underwent redesign before data collection. It included indicators lifetime receipt an ADHD by care provider, whether child currently had ADHD,...

10.1080/15374416.2017.1417860 article EN Journal of Clinical Child & Adolescent Psychology 2018-01-24

OBJECTIVES: To study the national prevalence of 10 developmental disabilities in US children aged 3 to 17 years and explore changes over time by associated demographic socioeconomic characteristics, using National Health Interview Survey. METHODS: Data come from 2009 2017 Survey, a nationally representative survey civilian noninstitutionalized population. Parents reported physician or other health care professional diagnoses attention-deficit/hyperactivity disorder; autism spectrum...

10.1542/peds.2019-0811 article EN PEDIATRICS 2019-09-26

<h3>Importance</h3> Information on underlying conditions and severe COVID-19 illness among children is limited. <h3>Objective</h3> To examine the risk of associated with medical complexity. <h3>Design, Setting, Participants</h3> This cross-sectional study included patients aged 18 years younger with<i>International Statistical Classification Diseases, Tenth Revision, Clinical Modification </i>code U07.1 (COVID-19) or B97.29 (other coronavirus) during an emergency department inpatient...

10.1001/jamanetworkopen.2021.11182 article EN cc-by-nc-nd JAMA Network Open 2021-06-07

Abstract Background Data on risk factors for coronavirus disease 2019 (COVID-19)–associated hospitalization are needed to guide prevention efforts and clinical care. We sought identify independently associated with COVID-19–associated hospitalizations. Methods Community-dwelling adults (aged ≥18 years) in the United States hospitalized laboratory-confirmed COVID-19 during 1 March–23 June 2020 were identified from COVID-19–Associated Hospitalization Surveillance Network (COVID-NET), a...

10.1093/cid/ciaa1419 article EN public-domain Clinical Infectious Diseases 2020-09-17

Preventing Chronic Disease (PCD) is a peer-reviewed electronic journal established by the National Center for Prevention and Health Promotion. PCD provides an open exchange of information knowledge among researchers, practitioners, policy makers, others who strive to improve health public through chronic disease prevention.

10.5888/pcd18.210123 article EN public-domain Preventing Chronic Disease 2021-06-28

Since August 2019, CDC, the Food and Drug Administration (FDA), state local health departments, public clinical stakeholders have been investigating a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). This report updates patient demographic characteristics, self-reported substance use, hospitalization dates for EVALI patients reported to CDC by states, as well distribution emergency department (ED) visits related products analyzed through National...

10.15585/mmwr.mm6903e2 article EN MMWR Morbidity and Mortality Weekly Report 2020-01-17

Pregnant women living in or traveling to areas with local mosquito-borne Zika virus transmission are at risk for infection, which can lead severe fetal and infant brain abnormalities microcephaly (1). In February 2016, CDC recommended 1) routine testing infection of asymptomatic pregnant ongoing the first prenatal care visit, 2) retesting during second trimester who initially test negative, 3) signs symptoms consistent disease (e.g., fever, rash, arthralgia, conjunctivitis) any time...

10.15585/mmwr.mm6623e1 article EN MMWR Morbidity and Mortality Weekly Report 2017-06-08

Childhood mental, behavioral, and developmental disorders (MBDDs) are associated with adverse outcomes that can persist into adulthood (1,2). Pediatric clinical settings important for identifying treating MBDDs (3). Early identification treatment of promote healthy development all children (4), especially those living in poverty who at increased risk (3,5) but might have reduced access to care (6). CDC analyzed data from the 2016 National Survey Children's Health (NSCH) on MBDDs, factors,...

10.15585/mmwr.mm6750a1 article EN MMWR Morbidity and Mortality Weekly Report 2018-12-20

Prescription stimulant use, primarily for the treatment of attention-deficit/hyperactivity disorder (ADHD), has increased among adults in United States during recent decades, while remaining stable or declining children and adolescents (1,2). MarketScan commercial claims data were analyzed to describe trends prescription fills before COVID-19 pandemic (2016-2021) by calculating annual percentages enrollees aged 5-64 years employer-sponsored health plans who had one more overall sex age...

10.15585/mmwr.mm7213a1 article EN MMWR Morbidity and Mortality Weekly Report 2023-03-30

To provide updated national prevalence estimates of diagnosed attention-deficit/hyperactivity disorder (ADHD), ADHD severity, co-occurring disorders, and receipt medication behavioral treatment among U.S. children adolescents by demographic clinical subgroups using data from the 2022 National Survey Children's Health (NSCH).

10.1080/15374416.2024.2335625 article EN other-oa Journal of Clinical Child & Adolescent Psychology 2024-05-03

Objective: Investigate the prevalence and impact of psychiatric comorbidities in community-based samples schoolchildren with/without ADHD. Method: Teachers parents screened children South Carolina (SC; n = 4,604) Oklahoma (OK; 12,626) for Parents high-screen selected low-screen received diagnostic interviews (SC: 479; OK: 577). Results: Psychiatric disorders were increased among with ADHD associated low academic performance. Conduct disorder/oppositional defiant disorder (CD/ODD) grade...

10.1177/1087054715613437 article EN Journal of Attention Disorders 2015-11-25

As of January 7, 2020, a total 2558 hospitalized patients with nonfatal cases and 60 fatal e-cigarette, or vaping, product use-associated lung injury (EVALI) had been reported to the Centers for Disease Control Prevention (CDC).In national study, we compared characteristics EVALI those improve ability clinicians identify at increased risk death from condition. Health departments CDC included, when available, data medical-record abstractions patient interviews. Analyses included all that were...

10.1056/nejmoa1915314 article EN New England Journal of Medicine 2020-04-22

CDC, the Food and Drug Administration (FDA), state local health departments, public clinical stakeholders continue to investigate a nationwide outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). EVALI patients in Illinois, Utah, Wisconsin acquired tetrahydrocannabinol (THC)-containing products primarily from informal sources (2,3). This report updates demographic characteristics self-reported THC- nicotine-containing derived patient data reported CDC by...

10.15585/mmwr.mm6902e2 article EN MMWR Morbidity and Mortality Weekly Report 2020-01-14

Older adults and people from certain racial ethnic groups are disproportionately represented in coronavirus disease 2019 (COVID-19) hospitalizations deaths.Using data the Premier Healthcare Database on 181 813 hospitalized diagnosed with COVID-19 during March-September 2020, we applied multivariable log-binomial regression to assess associations between age race/ethnicity clinical severity (intensive care unit [ICU] admission, invasive mechanical ventilation [IMV], death) determine whether...

10.1093/ofid/ofaa638 article EN cc-by-nc-nd Open Forum Infectious Diseases 2020-12-28

To provide state-level estimates of diagnosed ADHD and associated treatment among children in the United States 2016 to 2019.This study used National Survey Children's Health produce national lifetime diagnosis current all aged 3 17 years (n=114,476), medication behavioral use with ADHD.The ranged from 6.1% 16.3%. Among ADHD, usage 37.8% 81.4%, 38.8% 61.8%.There was substantial variation for indicators treatment. These results can be by policymakers, public health practitioners, care...

10.1177/10870547221099961 article EN Journal of Attention Disorders 2022-05-22

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental that develops during childhood and can last into adulthood. Data from the National Center for Health Statistics Rapid Surveys System collected October-November 2023 were used to estimate prevalence of ADHD diagnosis treatment among U.S. adults. In 2023, an estimated 15.5 million adults (6.0%) had current based on self-report; approximately one half received at age ≥18 years. Approximately third with took stimulant...

10.15585/mmwr.mm7340a1 article EN MMWR Morbidity and Mortality Weekly Report 2024-10-10

Objective: To describe the epidemiology of ADHD in communities using a DSM-IVTR case definition. Method: This community-based study used multiple informants to develop and apply DSM -IVTR-based definition screening diagnostic interview data collected for children 5-13 years age. Teachers screened 10,427 (66.4%) four school districts across two states (SC OK). ratings by teachers parent reports diagnosis medication treatment were stratify into high low risk ADHD. Parents (n = 855) gender...

10.1177/1087054712453169 article EN Journal of Attention Disorders 2012-09-05

The authors examined the interface between visual impairment and depressive symptoms on health behaviors, self-care, social participation among adults ages 65 older.The analyzed data from 1997-2004 National Health Interview Survey for 49,278 older, comparing visually impaired (n = 8,787) with without a reference group of neither condition 3,136) outcome measures: physical health, difficulties self-care participation.Adults severe were more likely than to smoke (14.9%, adjusted odds ratio...

10.1037/a0015910 article EN Rehabilitation Psychology 2009-01-01
Coming Soon ...